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Abstract
Cataract surgery decreases significantly and with maintained effect intraocular 
pressure (IOP) in both normal eyes as in eyes with glaucoma. In patients with cataracts 
and glaucoma, it can be performed, isolated or in combination with other techniques, 
such as the following: minimally invasive glaucoma surgery (MIGS) in patients with 
mild/moderate glaucoma that do not require a high tensional decrease; and conven-
tional glaucoma surgery techniques in patients with advanced glaucoma. Although 
lower than with conventional techniques, MIGS trabecular surgery has a good IOP 
lowering effect and provides some of the following advantages: a more physiological 
approach; little traumatic; without bleb; and it does not limit other techniques in the 
future. Different techniques that combinated or not with cataract surgery facilitate the 
exit of aqueous humor through the trabecular meshwork (TM) have been described. 
Our aim in this chapter is to review the newest of them, such as the following: iStent; 
ELT (Excimer Laser Trabeculostomy); kahook; ABiC; and OMNI.
Keywords: cataract surgery, glaucoma surgery, MIGS, iStent, ELT, Kahook, ABiC, 
OMNI
1. Introduction
It has been shown that after phacoemulsification in eyes with and without glau-
coma, there is a decrease in IOP in relation to the preoperative one, with a decrease 
of up to 8.5 mmHg, 34% of the preoperative IOP, in eyes with glaucoma and IOP 
between 29 and 23 mmHg and 3.4 mmHg; and 18% of the IOP in eyes with preop-
erative IOP lower than 20 mmHg [1]. Moreover, the decrease in IOP is maintained 
up to 10 years follow-up without influence of the age of the patients [1]. Therefore, 
we can affirm that the cataract extraction, regardless of the surgical technique 
used, provides a reduction in preoperative IOP, maintained during follow-up, which 
is related to preoperative, both in normal eyes and in ocular hypertensive with 
or without treatment, and even in eyes with glaucoma and hypotensive medical 
treatment. Therefore, cataract surgery can be considered as an antiglaucomatous 
surgical technique, which could the indicated treatment in hyperopic eyes and 
adequate glaucoma control with medical treatment and in glaucomatous patients, 
with correct medical control, if we do not pursue a large decrease in IOP [2].
However, when a big IOP decrease is required or in the case of advanced glaucomas, 
we will use the classic surgical techniques for the treatment of glaucoma: trabeculectomy 
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or nonpenetrating glaucoma surgery, as they present the highest hypotensive efficacy 
(but also a higher rate of complications than other less invasive techniques).
As an intermediate step, in mild or moderate glaucomas that do not require 
a high tensional decrease but in which an additional decrease in IOP than that 
obtained with isolated cataract surgery is needed, we can associate MIGS techniques 
with cataract surgery, since they offer good tensional responses (although smaller 
than those obtained with classical glaucoma surgeries) with a lower complication 
rate (both in number and severity) than with classical surgical techniques. All 
MIGS have in common a better postoperative recovery compared to other more 
invasive filtering procedures, the absence of complications associated with the bleb, 
the respect of the conjunctiva that will allow future techniques if required and the 
possibility of being performed easily in combination with cataract surgery.
In the following chapter, we are going to talk about the role of the trabecular 
approach and the MIGS techniques that use this approach associated with cataract 
surgery.
2. Anatomy of the trabecular meshwork
As we know, there are three ways of draining the aqueous humor [3]:
1. The conjunctival pathway.
2. The trabecular pathway.
3. The suprachoroidal pathway.
All three routes can be surgically approached both ab interno and ab externo.
The trabecular pathway is the physiological drainage pathway and it is where 
most of the keys of the pathophysiology of many types of glaucoma lie.
The trabecular pathway allows the aqueous humor to pass from the anterior 
chamber to the systemic circulation and we should see it like a dynamic mechanism 
instead of like a static mechanism.
1. The first structure in contact with the aqueous humor is the trabecular 
 meshwork (TM). In the TM we differentiate three zones [3]:
a. The uveal TM (Figure 1): it is located adjacent to the anterior chamber and 
is arranged in bands that extend from the root of the iris and the ciliary body 
to the peripheral cornea.
b. The corneo-scleral TM (Figure 1): it consists of trabecular sheets that extend 
from the scleral spur to the lateral wall of the scleral groove.
c. The juxtacanalicular TM (Figure 1): it forms the inner wall of the canal of 
Schlemm and the aqueous humor moves through and between the endothe-
lial cells that line the inner wall of the canal of Schlemm. As we advance in 
these areas, the difficulty of the aqueous humor outflow increases, so it is 
believed that the juxtacanalicular TM is the main site of resistance to the 
outflow of the aqueous humor.
The TM is a pressure sensitive drainage site and acts as a one-way valve, regard-
less of the energy. Furthermore, its cells are phagocytic and can exhibit this func-
tion in the presence of inflammation and after laser trabeculoplasty [3].
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We should not understand this system as a succession of static networks. We 
should understand it as a tissue embedded in an extracellular matrix in which there 
is a continuous intra and extracellular filtration towards the Schlemm’s canal (SC), 
in which there is a progressive deterioration in the case of eyes with glaucoma. Thus, 
in eyes with glaucoma, there are some alterations that will produce rigidity of this 
tissue difficulting the drainage of the aqueous humor.
2. The SC (Figure 1) is a single canal that surrounds the anterior chamber 360° 
and has a diameter of 200–300 μm [3]. SC is lined with an endothelial layer 
that rests on a discontinuous basement membrane [3]. It is not a homogeneous 
or rigid conduit. Microscopically it is a complex structure, as it is crossed by 
tubules and has partitions and duplications and has some structures such as 
cylindrical anchoring structures that communicate the trabecular face with 
the mouth of the collecting tubules that perform a valve-like function [3]. The 
outer wall of the Schlemm’s canal is made up of single-layered cells of endo-
thelium without pores [3]. With OCT we can also appreciate how the canal and 
the trabecular meshwork modifies with changes in IOP [4].
3. Finally we have the complex formed by the collectors, venous plexuses and 
the aqueous veins [3]. It is a complex system of vessels with abundant arterio-
venous anastomoses, in which the transmission of the heartbeat is essential, 
and whose function is to carry the aqueous humor from SC to the systemic 
Figure 1. 
Trabecular meshwork (uveal, corneo-scleral and juxtacanalicular); Schlemm’s canal.
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 circulation (it connects SC with the episcleral veins, that drain into the an-
terior and superior ciliary ophthalmic veins, which drain into the cavernous 
sinus) [3]. The organization of the collectors is not homogeneous, since they 
are mainly found in the lower nasal area.
In summary:
• The trabecular pathway is a dynamic tissue that has a pumping system towards 
the systemic circulation and is influenced by IOP changes (especially blinking, 
ocular pulse, eye movements).
• In glaucoma there are some ultrastructural alterations that will produce a loss 
of elasticity of the trabecular pathway and therefore a decrease in aqueous 
humor filtration.
• These changes are more important in the juxtacanalicular portion of the TM.
• It is logical that the trabecular pathway is more or less affected depending on 
the type of glaucoma. A mild, incipient glaucoma, with a few years of evolu-
tion, will have less structural alterations than an advanced glaucoma, with 
more years of evolution and that requires 2–3 drugs for its control.
• In the same way, the different anatomical alterations will produce a greater 
or lesser alteration of the TM. For example, a glaucoma that does not present 
any alteration in gonioscopy is different than a pseudoexfoliative glaucoma, in 
which the pigment enters in the TM and the rest of the angular structures, or a 
pigment dispersion glaucoma, in which the pigment permeates very intensively 
the entire TM.
3. Types of migs techniques in the trabecular pathway
All the surgical routes of the trabecular route seek the same aim (to facilitate the 
exit of aqueous humor from the anterior chamber to the systemic circulation) but 
they achieve it in different ways.
a. Some techniques perform microperforations, either with an implant (iStent) or 
with a laser (ELT).
b. Others perform a rupture of the internal wall of the shlemm canal and the 
trabecular meshwork (trabectome, Kahook, OMNI).
c. Others perform a viscodilation of the SC, leading to the distension of the Schlemm 
canal, of the trabecular meshwork and of the collecting canals (ABiC, OMNI).
We can also differentiate the surgeries based on the area that they treat:
a. Some provide a punctual treatment (iStent).
b. Others treat a sector, normally 90° (ELT, trabectome, Kahook).
c. Others treat the entire circumference (360°) of the SC (OMNI, ABiC, GATT).
Some of these techniques are detailed below.
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It is an ab-interno MIGS technique in which two implants are applied in a specific 
way on the TM [5]. IStent is the smallest device ever implanted in humans [5]. It is 
a titanium implant surrounded by a layer of heparin, which allows better passage 
of the aqueous humor through the lumen of the iStent [5]. It has a long portion that 
enters the Schlemm’s canal and a short portion that crosses the TM and connects 
with the anterior chamber [5]. The distal portion is beveled and tapered to facilitate 
penetration through the TM tissue and on the external surface it has three ridges 
that prevent its expulsion once inserted [5]. The Glaukos® GTS-400 trabecular 
implant has an applicator and a button to release the device and comes preloaded 
with two iStent, allowing the implantation of both iStent with a single applicator [5].
3.1.2 Indications and contraindications
This implant is ideal for surgery combined with phacoemulsification, since 
the angle is easier to visualize in pseudophakic eyes [5]. Thus, IStent is indicated 
in combined use with cataract surgery for reduction of IOP in adult patients with 
mild–moderate open angle glaucoma (OAG) under treatment with topical hypoten-
sive drugs and cataract in surgical stage [5].
It is contraindicated in patients with both primary and secondary angle closure 
glaucoma, including neovascular glaucoma, as well as in patients with retrobulbar 
tumors, thyroid orbitopathy, Sturge–Weber Syndrome or any other situation that 
may cause elevated episcleral venous pressure [5].
A gonioscopy should be performed prior to surgery to exclude peripheral ante-
rior synechiae, rubeosis or any other abnormality of the chamber angle that may 
hinder a correct visualization of the angle that could produce a possible incorrect 
placement of the iStent [5].
3.1.3 Surgical technique
For a safe surgery, it is essential to obtain a good visualization of the chamber 
angle by turning the patient’s head 45° towards the opposite side of the operated eye 
and tilting the head of the surgical microscope 30° [5]. Intracamerular acetylcholine 
injection is first performed to constrict the pupil and the anterior chamber (AC) is 
filled with cohesive viscoelastic [5]. The main incision made for phacoemulsifica-
tion is used to introduce the implant through the AC into the TM, while viewing 
the angle with gonioscopy and, once the insertion site is located, the tip of the 
implant (bevelled) is inserted into the TM, at an angle of about 15°, which facilitates 
penetration into the tissue, with the iStent tip pointing towards the patient’s feet 
[4]. When it is verified that the TM covers the entire implant, it is released with the 
button of the applicator [5]. A small backflow of blood from the SC is frequent and 
reflects the proper position of the iStent [5]. Finally, the applicator is removed, the 
viscoelastic is washed and the corneal incision is sealed by hydrating the stroma [4]. 
In Figure 2(A) we can see two iStent correctly implanted in the TM.
3.1.4 Security
Trabecular stent implantation is a safe procedure with limited complications 
and no severe adverse events [5]. The most common of complications is implant 
obstruction and malposition [5]. The appearance of minimal hyphema during 
surgery is a sign of correct implant placement [5].




ELT is an ab-interno MIGS technique in which microperforations or trabeculos-
tomies are performed in the TM in order to facilitate the drainage of aqueous humor 
towards the SC using excimer laser impacts in a sectorial way (90°) of the TM [5]. 
Excimer laser photocoagulation allows the ablation of the juxtacanalicular wall of 
the TM and the internal wall of the Schlemm canal (avoiding injury to the external 
wall of the Schlemm canal containing fibroblasts, whose preservation is important 
for the drainage of the aqueous humor) with local and adjacent temperature control 
avoiding thermal damage to surrounding tissues [5].
3.2.2 Indications and contraindications
The effectiveness of ELT is greater when performed in combination with 
cataract surgery [6]. Therefore, it is indicated alone or in combination with cataract 
surgery in most patients with OAG with hypotensive treatment and cataract in 
surgical stage to reduce IOP and medication [5].
It is not indicated in glaucomas with increased episcleral venous pressure or in 
those requiring very low target IOPs below episcleral venous pressure [5].
3.2.3 Surgical technique
The AC is filled with viscoelastic using the corneal incision made for cataract 
surgery and the probe is positioned in contact with the TM, which can be visual-
ized by gonioscopy (Figure 2(C)) or by endoscopy, depending on the generation 
of the laser used [5]. Between 8 and 10 laser microperforations are made per 
90° sector of the TM [5]. The parameters used by the laser are: 200 μm spot, 
1.2 mJ pulse energy, 80 ns duration [5]. During the application of the laser, the 
whitening of the TM and the appearance of one or more bubbles are observed. 
Figure 2. 
Surgical procedures. (A) Two iStent correctly implanted in the TM. (B) Kahook mades a cut along the TM  in 
a clockwise direction, followed by another cut in an anti-clockwise direction. (C) During the application of 
the laser in ELT, the whitening of the TM and the appearance of one or more bubbles are observed. (D) OMNI 
introduces the blue microcatheter in the SC, first for 180º of the SC and then the process is repeated for the 
second 180º.
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(Figure 2(C)), sometimes associated with a slight reflux of blood that confirms 
the opening of the SC [5]. Finally, the probe is removed, the viscoelastic is washed, 
and the corneal incision is sealed by hydrating the stroma [5].
3.2.4 Security
This is a simple technique with a low incidence of complications. The main 
complications include hemorrhage in the immediate postoperative period and the 
fact that, due to the small size of the perforations, they are more easily obstructed 
than larger openings obtained with other procedures [5].
ELT can be performed on eyes that have previously undergone filtering surgery [5].
Its application in only 90° per session allows retreatment in the 3 remaining 
sectors in future interventions [5].
3.3 Kahook
3.3.1 Definition
It is a sectoral (90°) ab-interno MIGS technique in which the TM and the internal 
wall of the canal are bundled (similar to the procedure performed with the trabec-
tome) with a device that is inserted into the TM and consists of a ramp in the distal 
end that, as we advance in the cut, raises the TM tissue and directs it towards 2 blades 
at the ends of the ramp that allow the cutting and extraction of this tissue [5].
3.3.2 Indications and contraindications
Thanks to its approach, it can be easily combined with cataract surgery and the 
combination of both surgeries increases hypotensive efficacy [7, 8]. Therefore, it is 
indicated in different types of OAG (primary, secondary to pseudoexfoliation and 
pigment dispersion, corticosteroid and uveitic), with mild or moderate glaucoma 
damage in a stage prior to conventional surgery, combined with cataract surgery 
in patients with cataract in the surgical stage in whom a decrease in IOP and/or a 
reduction in topical hypotensive medication is desired [5].
It should not be used in patients with advanced glaucoma or with a target IOP 
lower than episcleral venous pressure [5].
3.3.3 Surgical technique
The patient’s head should be turned to the opposite side of the eye to be treated 
[5]. The corneal incision of cataract surgery is used to inject cohesive viscoelastic 
and introduce the kahook, which advances through the anterior chamber towards 
the nasal angle sector, which is visualized by gonioscopy [5]. The tip of the kahook 
is inserted through the TM into SC, and a cut is made along the TM in a clockwise 
direction, followed by another cut in an anti-clockwise direction, using the inser-
tion site as a point of attachment reference (Figure 2(B)) [5]. The reflux of blood 
confirms the opening of the SC [5]. Finally, the device is removed, the viscoelastic is 
washed, and the corneal incision is sealed by hydrating the stroma [5].
3.3.4 Security
The complication rate is low and comparable to that of Trabectome™, highlight-
ing the bleeding in the anterior chamber [9].




Ab-interno canaloplasty (ABiC) is an ab-interno MIGS that viscodilate de TM, 
SC and the collerctor channels 360° inserting a microcatheter [10].
3.4.2 Indications and contraindications
ABiC is effective at reducing IOP and medication use in eyes with uncontrolled 
primary open-angle glaucoma (POAG) with or without cataract surgery [9]. It is 
useful in combination with cataract surgery as incisions resemble those of a typical 
cataract extraction and the IOP lowering effect of both procedures is enhanced [10]. 
Moreover, the addition of ABiC to phacoemulsification could be considered astig-
matically neutral [10].
As in the resto of MIGS, the epiescleral venous-resistant floor limits the IOP-
lowering effect, so ABiC seems to be indicated such as a minimal invasive technique 
that does not affect future conjunctival bleb surgeries in patients with or without 
cataracts and POAG that need a modest IOP-lowering effect in order to reduce IOP 
or medication [10].
3.4.3 Surgical technique
After cataract surgery, the side port corneal incision is used in order to introduce 
viscoelastic and the microcatheter towards the nasal angle [10]. A side port incision 
for the iTrack™ microcatheter is created approximately 90° away from de nasal 
drainage angle, wich is inserted into the AC with te catheter tip guided towards the 
nasal angle [10]. A 25 G needle or a Cystotome® is used to perform a micro-goniot-
omy in the nasal TM under visualization using a gonioprism [9]. The microcatheter 
is held by a micro-surgical forceps and the SC is intubated inserting the catheter 
through the goniotomy until complete the circumferential intubation of SC 360° 
[10]. After that, the catheter is slowly withdrawn while infusing viscoelastic every 
clock hour [9]. Finally, the catether is removed, the viscoelastic is washed, and the 
corneal incision is sealed by hydrating the stroma [10].
3.4.4 Security
ABiC shows no serious adverse events and less complications compared to more 
invasive conventional techniques; adverse events are limited to intraoperative 
bleeding at the goniotomy site and postoperative microhyphema [10].
3.5 OMNI
3.5.1 Definition
OMNI™ Surgical System is an ab-interno MIGS that combines two functions 
into one device: microcatherization and vascodilation in up to 360° of the SC (open 
distal outflow pathway) and cutting of the TM (controlled and Customizable 
trabeculotomy that removes the resistance of the TM) using a single fully inte-
grated handheld system [11]. The system has got a luer fitting that allows for 
efficient priming of the device with viscoelastic, a priming lock, a reservoir where 
microcatheter is retracted, the gears whose movilization with the finger facilitate 
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microcatheter deployment and retraction, a cannula with a beleved tip that allows 
for precise acces to target tissues, viscoelastic fluid and a blue microcatheter.
3.5.2 Indications and contraindications
As other MIGS techniques, OMNI can be used isolated or easily in conjunction 
with cataract surgery, in mild or moderated POAG that do not require a big IOP-
lowering effect, with a minimal invasive approach and avoiding bleb complications 
and without conditioning future conjunctival bleb surgeries [11].
3.5.3 Surgical technique
The head of the patient and the microscope are tilted 30–40° and OMNI is 
introduced using the temporal clear corneal incision of the cataract surgery towards 
the nasal angle [11]. A small (<1 mm) goniotomy is created with the cannula tip in 
order to introduce the microcatheter for 180° of the SC under gonioscopic visualiza-
tion (Figure 2(D)) [11]. Viscoelastic is delivered for viscodilation while microcath-
eter is retracted [11]. Microcatheter is again advanced and withdrawn with a 90° 
traction causing the unroof the SC (trabeculotomy) [11]. The process is repeated for 
the second 180° [10]. This technique allows varying the intensity of the treatment: 
for example, we can perform a 360° viscodylation and a 180° trabeculotomy.
3.5.4 Security
Adverse events are generally mild, nonseriuous and transient and include ante-
rior chamber inflammation, posterior capsular opaciticity, IOP > 10 mmHg above 
baseline more than 30 days postoperatively, cystoid macular edema, corneal edema 
and hyphema [11].
4. Scientific evidence
Some techniques perform a more aggressive treatment than others. It is logical to 
think that the less aggressive techniques will be used in eyes with glaucoma where 
the involvement of the TM is smaller, and that, on the contrary, the more aggressive 
techniques, such as the trabeculotomy with viscodilatation, will be used in cases 
where the involvement of the TM is much more intense.
If we review the literature in order to compare the different surgical techniques 
[12–21], we see that, except in some surgical techniques, in the most of the tech-
niques, most of the studies present biases: they are not randomized, they are not 
prospective, they are simple series, they do not have washout, they use personal 
criteria, they do not record complications … therefore, we can affirm that the scien-
tific evidence for MIGS surgery in comparison with other techniques is very limited, 
although it has been demonstrated a decrease in IOP, a decrease in the number of 
drugs and a decrease in complications.
If we focus on surgical success, understanding it such as a IOP reduction greater 
than 20%, most techniques reach a rate success of 60–80% (Table 1). Evidence A 
and B can only be found with the iStent, the Hydrus and the trabectome, while in 
OMNI and Kahook the grade of recommendation is C (Table 1).
If we focus on the IOP that these surgical techniques achieve, we see that in the 
most of the cases the IOP reached is between 15 and 17 mmHg (Table 2), a limita-
tion that is given by the episcleral venous pressure.
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5. Conclusion
Taking all together, we can conclude with the following question: what can we 
expect from trabecular MIGS?
• MIGS are surgeries with a short learning technique, little aggressive and with a 
fast execution.
• They have few and little severe complications.
• They do not influence the possibility of performing surgeries with conjunctival 
bleb in the future if required.
• If we focus on the results, we will have a decrease greater than 20% in almost 
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Table 2. 
IOP achieved with different MIGS techniques.
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• However, the target pressure they achieve is approximately 16 mmHg. This 
means that they can be useful in eyes with mild or moderate glaucoma that do 
not require a big IOP decrease, but that in eyes with advanced glaucoma, where 
we look forward an IOP below 15 mmHg, trabecular MIGS techniques are not 
the most appropriate.
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